Sangam: A Confluence of Knowledge Streams

Bisphenol A‐associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver

Show simple item record

dc.creator Nahar, Muna S.
dc.creator Kim, Jung H.
dc.creator Sartor, Maureen A.
dc.creator Dolinoy, Dana C.
dc.date 2014-05-21T18:02:38Z
dc.date WITHHELD_13_MONTHS
dc.date 2014-05-21T18:02:38Z
dc.date 2014-04
dc.date.accessioned 2022-05-19T13:30:42Z
dc.date.available 2022-05-19T13:30:42Z
dc.identifier Nahar, Muna S.; Kim, Jung H.; Sartor, Maureen A.; Dolinoy, Dana C. (2014). "Bisphenol A‐associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver." Environmental and Molecular Mutagenesis 55(3): 184-195.
dc.identifier 0893-6692
dc.identifier 1098-2280
dc.identifier http://hdl.handle.net/2027.42/106679
dc.identifier 10.1002/em.21823
dc.identifier Environmental and Molecular Mutagenesis
dc.identifier Sengupta S, Bolin JM, Ruotti V, Nguyen BK, Thomson JA, Elwell AL, Stewart R. 2011. Single read and paired end mRNA‐Seq Illumina libraries from 10 nanograms total RNA. J Vis Exp: e3340.
dc.identifier Kundakovic M, Champagne FA. 2011. Epigenetic perspective on the developmental effects of bisphenol A. Brain Behav Immun 25: 1084 – 1093.
dc.identifier Kyriakis JM, Avruch J. 2001. Mammalian mitogen‐activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 81: 807 – 869.
dc.identifier McCarver DG, Hines RN. 2002. The ontogeny of human drug‐metabolizing enzymes: Phase II conjugation enzymes and regulatory mechanisms. J Pharmacol Exp Ther 300: 361 – 366.
dc.identifier Molina‐Molina JM, Amaya E, Grimaldi M, Saenz JM, Real M, Fernandez MF, Balaguer P, Olea N. 2013. In vitro study on the agonistic and antagonistic activities of bisphenol‐S and other bisphenol‐A congeners and derivatives via nuclear receptors. Toxicol Appl Pharmacol 272: 127 – 136.
dc.identifier Naciff JM, Khambatta ZS, Reichling TD, Carr GJ, Tiesman JP, Singleton DW, Khan SA, Daston GP. 2010. The genomic response of Ishikawa cells to bisphenol A exposure is dose‐ and time‐dependent. Toxicology 270: 137 – 149.
dc.identifier Nahar MS, Liao C, Kannan K, Dolinoy DC. 2012. Fetal liver bisphenol A concentrations and biotransformation gene expression reveal variable exposure and altered capacity for metabolism in humans. J Biochem Mol Toxicol 27: 116 – 123.
dc.identifier O'Shaughnessy PJ, Monteiro A, Bhattacharya S, Fraser MJ, Fowler PA. 2013. Steroidogenic enzyme expression in the human fetal liver and potential role in the endocrinology of pregnancy. Mol Hum Reprod 19: 177 – 187.
dc.identifier Omiecinski CJ, Aicher L, Swenson L. 1994. Developmental expression of human microsomal epoxide hydrolase. J Pharmacol Exp Ther 269: 417 – 423.
dc.identifier Pfeiffer E, Metzler M. 2004. Effect of bisphenol A on drug metabolising enzymes in rat hepatic microsomes and precision‐cut rat liver slices. Arch Toxicol 78: 369 – 377.
dc.identifier Rubin BS. 2011. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J Steroid Biochem Mol Biol 127: 27 – 34.
dc.identifier Saghir SA, Khan SA, McCoy AT. 2012. Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies. Crit Rev Toxicol 42: 323 – 357.
dc.identifier Schonfelder G, Wittfoht W, Hopp H, Talsness CE, Paul M, Chahoud I. 2002. Parent bisphenol A accumulation in the human maternal‐fetal‐placental unit. Environ Health Perspect 110: 703 – 707.
dc.identifier Smith M, Hopkinson DA, Harris H. 1971. Developmental changes and polymorphism in human alcohol dehydrogenase. Ann Hum Genet 34: 251 – 271.
dc.identifier Smyth GK. 2004. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3: Article3.
dc.identifier Strange RC, Howie AF, Hume R, Matharoo B, Bell J, Hiley C, Jones P, Beckett GJ. 1989. The development expression of alpha‐, mu‐ and pi‐class glutathione S ‐transferases in human liver. Biochim Biophys Acta 993: 186 – 190.
dc.identifier Suganuma T, Workman JL. 2012. MAP kinases and histone modification. J Mol Cell Biol 4: 348 – 350.
dc.identifier Timens W, Kamps WA. 1997. Hemopoiesis in human fetal and embryonic liver. Microsc Res Tech 39: 387 – 397.
dc.identifier Vogel C, Marcotte EM. 2012. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 13: 227 – 232.
dc.identifier Wang H, Ping J, Peng RX, Yue J, Xia XY, Li QX, Kong R, Hong JY. 2008. Changes of multiple biotransformation phase I and phase II enzyme activities in human fetal adrenals during fetal development. Acta Pharmacol Sin 29: 231 – 238.
dc.identifier Watanabe H, Adachi R, Kusui K, Hirayama A, Kasahara T, Suzuki K. 2003. Bisphenol A significantly enhances the neutrophilic differentiation of promyelocytic HL‐60 cells. Int Immunopharmacol 3: 1601 – 1608.
dc.identifier Watson CS, Jeng YJ, Guptarak J. 2011. Endocrine disruption via estrogen receptors that participate in nongenomic signaling pathways. J Steroid Biochem Mol Biol 127: 44 – 50.
dc.identifier Wetherill YB, Akingbemi BT, Kanno J, McLachlan JA, Nadal A, Sonnenschein C, Watson CS, Zoeller RT, Belcher SM. 2007. In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24: 178 – 198.
dc.identifier Yordy JS, Muise‐Helmericks RC. 2000. Signal transduction and the Ets family of transcription factors. Oncogene 19: 6503 – 6513.
dc.identifier Alcorn J, McNamara PJ. 2003. Pharmacokinetics in the newborn. Adv Drug Deliv Rev 55: 667 – 686.
dc.identifier Allegaert K, van den Anker JN, Naulaers G, de Hoon J. 2007. Determinants of drug metabolism in early neonatal life. Curr Clin Pharmacol 2: 23 – 29.
dc.identifier Allegaert K, Verbesselt R, Naulaers G, van den Anker JN, Rayyan M, Debeer A, de Hoon J. 2008. Developmental pharmacology: neonates are not just small adults. Acta Clin Belg 63: 16 – 24.
dc.identifier Anderson OS, Nahar MS, Faulk C, Jones TR, Liao C, Kannan K, Weinhouse C, Rozek LS, Dolinoy DC. 2012. Epigenetic responses following maternal dietary exposure to physiologically relevant levels of bisphenol A. Environ Mol Mutagen 53: 334 – 342.
dc.identifier Balakrishnan B, Henare K, Thorstensen EB, Ponnampalam AP, Mitchell MD. 2010. Transfer of bisphenol A across the human placenta. Am J Obstet Gynecol 202: 393 e391 – e397.
dc.identifier Bassuk AG, Leiden JM. 1995. A direct physical association between ETS and AP‐1 transcription factors in normal human T cells. Immunity 3: 223 – 237.
dc.identifier Benjamini Y, Hochberg Y. 1995. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Series B Stat Methodol 57: 289 – 300.
dc.identifier Bromer JG, Zhou Y, Taylor MB, Doherty L, Taylor HS. 2010. Bisphenol‐A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. FASEB J 24: 2273 – 2280.
dc.identifier Buterin T, Koch C, Naegeli H. 2006. Convergent transcriptional profiles induced by endogenous estrogen and distinct xenoestrogens in breast cancer cells. Carcinogenesis 27: 1567 – 1578.
dc.identifier Caldwell J, Gardner I, Swales N. 1995. An introduction to drug disposition: the basic principles of absorption, distribution, metabolism, and excretion. Toxicol Pathol 23: 102 – 114.
dc.identifier Cao XL, Zhang J, Goodyer CG, Hayward S, Cooke GM, Curran IH. 2012. Bisphenol A in human placental and fetal liver tissues collected from Greater Montreal area (Quebec) during 1998–2008. Chemosphere 89: 505 – 511.
dc.identifier Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T. 2005. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21: 2933 – 2942.
dc.identifier Chepelev NL, Enikanolaiye MI, Chepelev LL, Almohaisen A, Chen Q, Scoggan KA, Coughlan MC, Cao XL, Jin X, Willmore WG. 2013. Bisphenol A activates the Nrf1/2‐antioxidant response element pathway in HEK 293 cells. Chem Res Toxicol 26: 498 – 506.
dc.identifier Coolen MW, Statham AL, Gardiner‐Garden M, Clark SJ. 2007. Genomic profiling of CpG methylation and allelic specificity using quantitative high‐throughput mass spectrometry: critical evaluation and improvements. Nucleic Acids Res 35: e119.
dc.identifier Duanmu Z, Weckle A, Koukouritaki SB, Hines RN, Falany JL, Falany CN, Kocarek TA, Runge‐Morris M. 2006. Developmental expression of aryl, estrogen, and hydroxysteroid sulfotransferases in pre‐ and postnatal human liver. J Pharmacol Exp Ther 316: 1310 – 1317.
dc.identifier Hanet N, Lancon A, Delmas D, Jannin B, Chagnon MC, Cherkaoui‐Malki M, Latruffe N, Artur Y, Heydel JM. 2008. Effects of endocrine disruptors on genes associated with 17beta‐estradiol metabolism and excretion. Steroids 73: 1242 – 1251.
dc.identifier Hanioka N, Jinno H, Tanaka‐Kagawa T, Nishimura T, Ando M. 2000. Interaction of bisphenol A with rat hepatic cytochrome P450 enzymes. Chemosphere 41: 973 – 978.
dc.identifier Hanioka N, Takeda Y, Tanaka‐Kagawa T, Hayashi K, Jinno H, Narimatsu S. 2008. Interaction of bisphenol A with human UDP‐glucuronosyltransferase 1A6 enzyme. Environ Toxicol 23: 407 – 412.
dc.identifier Hines RN. 2007. Ontogeny of human hepatic cytochromes P450. J Biochem Mol Toxicol 21: 169 – 175.
dc.identifier Hines RN. 2008. The ontogeny of drug metabolism enzymes and implications for adverse drug events. Pharmacol Ther 118: 250 – 267.
dc.identifier Hines RN, McCarver DG. 2002. The ontogeny of human drug‐metabolizing enzymes: phase I oxidative enzymes. J Pharmacol Exp Ther 300: 355 – 360.
dc.identifier Ho SM, Tang WY, Belmonte de Frausto J, Prins GS. 2006. Developmental exposure to estradiol and bisphenol A increases susceptibility to prostate carcinogenesis and epigenetically regulates phosphodiesterase type 4 variant 4. Cancer Res 66: 5624 – 5632.
dc.identifier Hogart A, Lichtenberg J, Ajay SS, Anderson S, Margulies EH, Bodine DM. 2012. Genome‐wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal overrepresentation of ETS transcription factor binding sites. Genome Res 22: 1407 – 1418.
dc.identifier Hollenhorst PC, McIntosh LP, Graves BJ. 2011. Genomic and biochemical insights into the specificity of ETS transcription factors. Annu Rev Biochem 80: 437 – 471.
dc.identifier Jeong H. 2010. Altered drug metabolism during pregnancy: Hormonal regulation of drug‐metabolizing enzymes. Expert Opin Drug Metab Toxicol 6: 689 – 699.
dc.identifier Jiménez‐Díaz I, Zafra‐Gómez A, Ballesteros O, Navea N, Navalón A, Fernández MF, Olea N, Vílchez JL. 2010. Determination of Bisphenol A and its chlorinated derivatives in placental tissue samples by liquid chromatography‐tandem mass spectrometry. J Chromatogr B 878: 3363 – 3369.
dc.identifier Kennedy M. 2008. Hormonal regulation of hepatic drug‐metabolizing enzyme activity during adolescence. Clin Pharmacol Ther 84: 662 – 673.
dc.identifier.uri http://localhost:8080/xmlui/handle/CUHPOERS/117384
dc.description Peer Reviewed
dc.description http://deepblue.lib.umich.edu/bitstream/2027.42/106679/1/em21823.pdf
dc.format application/pdf
dc.publisher Wiley Periodicals, Inc.
dc.rights IndexNoFollow
dc.subject Transcription Factor
dc.subject Xenobiotic Metabolism
dc.subject Liver
dc.subject DNA Methylation
dc.subject Bisphenol A
dc.subject Biological Chemistry
dc.subject Genetics
dc.subject Molecular, Cellular and Developmental Biology
dc.subject Health Sciences
dc.subject Science
dc.title Bisphenol A‐associated alterations in the expression and epigenetic regulation of genes encoding xenobiotic metabolizing enzymes in human fetal liver
dc.type Article


Files in this item

Files Size Format View
em21823.pdf 322.6Kb application/pdf View/Open

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse